NASDAQ: IBRX · Biotechnology
Over the past week, ImmunityBio (IBRX) pulled in about 431 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 46% bullish but is sharply divided: X runs 70% bullish while Reddit sits at just 17%. Wall Street is more constructive, with 4 of 4 analysts rating IBRX a buy.
There is steady buzz around IBRX this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 17% to X at 70%. No other tracker puts the two side by side.
4 analysts have weighed in: a Strong Buy consensus: 4 buy calls against 0 sell, with an average 12-month price target of $12.75.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 54 points above the crowd average of 46%, the professionals are more constructive than retail. The split is inside the crowd: X reads 70% bullish while Reddit sits at 17%, a 53-point spread that single-source trackers miss.
Over the 30-day window, ImmunityBio (IBRX) buzz held moderate around 56.0 while the price drifted up 27.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 13M shares. Updated Oct 03, 2026. Over the last 7 trading days, IBRX gained 19.0%. Buzz activity in the recent week averaged 46.5 and was variable, swinging between 36.2 and 59.4. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 19 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for IBRX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live IBRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 03, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (4 / 0 / 0) |
| Crowd bullish (7d) | 46% |
| Avg price target | $12.75 |
| Most bullish source | X, 70% |
| Most bearish source | Reddit, 17% |
| Sentiment spread | 53 pts |
| Mentions (7d) | 431 |
| Market cap | $9.84B |
| P/E · Forward P/E | n/a · 123.5 |
| EPS · Beta | -$1.02 · 0.1 |
| Revenue (TTM) | $165.8M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, ImmunityBio (IBRX) currently carries an Adanos hold signal with 69/100 conviction. The current cross-source average reads 46% bullish across 3 active sources. Those sources contribute 431 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around ImmunityBio (IBRX) is fairly quiet with 24 mentions over the last 7 days; the 30-day context spans 13 tracked subreddits. The 7-day tone is 17% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads split on ImmunityBio (IBRX), averaging 46% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 70% bullish and Reddit at 17%, a 53-point spread. On the professional side, 4 of 4 analysts rate IBRX a buy.
Of the 4 analysts covering ImmunityBio (IBRX), 4 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $12.75. That puts the street ahead of the crowd, which averages 46% bullish.
ImmunityBio (IBRX)'s cross-source average is mixed at 46% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. X reads 70% bullish, News reads 50% bullish and reddit coverage is the most negative at 17% bullish. The combined signal points to broad mixed pressure with 69/100 conviction.
The cross-source average is mixed for ImmunityBio (IBRX) at 46% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is reddit at 17% bullish. 3-day activity momentum is falling across X and News. The hold signal carries 69/100 conviction.
X is the dominant discussion channel with 397 mentions (92% of total volume). Reddit contributes 24 mentions and News contributes 10 mentions. The cross-source average is mixed at 46% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. IBRX's hold signal at 69/100 conviction reflects a mixed cross-source average at 46% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The IBRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key